Tolera Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tolera.com
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
Phase 1
- Conditions
- Renal TransplantEnd Stage Renal Disease
- Interventions
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Tolera Therapeutics, Inc
- Target Recruit Count
- 85
- Registration Number
- NCT01154387
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Buffalo General Hospital, Buffalo, New York, United States
© Copyright 2025. All Rights Reserved by MedPath